1. From 1Allergan, Inc., Biological Sciences, Inflammation Research Program, Irvine, California; 2Baylor College of Medicine, Ocular Surface Center, Cullen Eye Institute, Houston, Texas; 3Department of Ocular Biology and Therapeutics, University College Lond